Home>Topics>Companies>King Pharmaceuticals

King Pharmaceuticals KG

  1. All
  2. Commentary
  3. Stock Reports
  4. Fund Reports
  5. ETF Reports
  6. Headlines
    1. Why Does This Former Pharma King Keep Buying Shares Of Tribute Pharmaceuticals?

      Headlines

      Wed, 9 Apr 2014

      than $150 million per year. Gregory parlayed the success of GIV into co-founding King Pharmaceuticals in 1993. With him at the helm as Chairman and CEO, King went on to grow from a company of less than 100 employees into an Complete Story

    2. New Morningstar Analyst Report for Zoetis Inc

      Stock Reports

      Mon, 31 Mar 2014

      Zoetis has recently seen margin improvement due to synergies from the acquisitions of Fort Dodge (Wyeth) and Alpharma ( King Pharma ) and from Pfizer's companywide cost-reduction program. Management expects continued margin expansion as a result

    3. RXL ProShares Ultra Health Care ETF Analysis, Report, Research, 5 Star Rating – Morningstar

      ETF Reports

      Tue, 18 Sep 2012

      acquisition of Genzyme, Merck of Germany's takeover of Millipore, and Pfizer's PFE acquisition of pain-drug maker King Pharmaceuticals . In our view, an ETF can help health-care investors diversify away company-specific risks. Granted, all

    4. PPH Market Vectors Pharmaceutical ETF ETF Analysis, Report, Research, 5 Star Rating – Morningstar

      ETF Reports

      Tue, 21 Aug 2012

      acquisition of Genzyme, Merck of Germany's takeover of Millipore, and Pfizer's PFE acquisition of pain-drug maker King Pharmaceuticals . In our view, an ETF makes a lot of sense for health-care investors. No matter how deep your knowledge of

    5. Covidien to Spin Out Pharmaceutical Business

      Commentary

      Thu, 15 Dec 2011

      based on our review of some of its peers, such as Endo Pharmaceuticals ENDP, as well as the recent acquisition of King Pharmaceuticals by Pfizer PFE and Bristol-Myers Squibb's BMY sale of its imaging business (which included branded Cardiolite

    6. Diamond Hill Small Cap Fund First Quarter Commentary

      Headlines

      Tue, 24 May 2011

      deals for food producer Del Monte Foods and drug maker King Pharmaceuticals closed. Del Monte was taken private by a KKR led consortium for $19 cash per share and King was acquired by Pfizer, Inc. for $14.25 per share

    7. Wall Street Breakfast: Must-Know News

      Headlines

      Thu, 17 Mar 2011

      issued a recall for an opioid painkiller it acquired just weeks ago when it completed its $3.6B purchase of King Pharmaceuticals . The drug, called Embeda, may be unavailable for many months because of formulation problems. Though Embeda

    8. Diamond Hill Small-Mid Cap Fourth Quarter Commentary

      Headlines

      Wed, 2 Feb 2011

      the health care sector, drug manufacturer King Pharmaceuticals , Inc. ( KG ) and medical diagnostic company Myriad Genetics ..... provided the largest contribution to return. King Pharmaceuticals agreed to be purchased by Pfizer at $14

    9. Diamond Hill Small Cap Fourth Quarter Commentary

      Headlines

      Tue, 1 Feb 2011

      contributors to performance included drug manufacturer King Pharmaceuticals , Inc. ( KG ) and semiconductor testing company Verigy Ltd (VRGY). King Pharmaceuticals agreed to be purchased by Pfizer at $14

    10. Pfizer's Acquisition of King Pharmaceuticals Should Wrap Up in 1Q

      Commentary

      Mon, 24 Jan 2011

      conditions, we expect the purchase of King Pharmaceuticals KG by Pfizer PFE to wind up by the ..... attractive premium to what we think King is worth on a stand-alone basis ..... synergies by the end of 2013. With King spending close to $550 million

    « Prev12345Next »
    Content Partners